
|
Washington, District of Columbia
Mr. Terman is a principal at Olsson Frank Weeda Terman Bode Matz P.C. He was born in Washington, D.C., and received his B.S. in economics in 1973 from the University of Maryland where he was Phi Kappa Phi and his J.D. in 1976, also from the University of Maryland. Mr. Terman was admitted to the Maryland Bar in 1976 and the District of Columbia Bar in 1979. He is currently a member of the District of Columbia Bar. Mr. Terman concentrates his practice in medical device law, FDA regulatory issues, and litigation. While at Olsson Frank Weeda Terman Bode Matz PC, he has represented over 200 corporations, individuals and associations in civil, criminal and regulatory matters. Mr. Terman's expertise covers all areas of medical device law including the Quality System Regulation, Medical Device Reporting, IDE, 510(k) and PMA submissions. He has helped companies respond to FDA inspectional observations, Warning Letters and recalls, as well as civil penalty actions, injunctions, clinical disqualifications and criminal prosecutions. Until joining the firm in 1990, he served as Associate General Counsel of the former Health Industry Manufacturers Association (HIMA) now AdvaMed, a national trade association representing over 300 medical device, diagnostic product and healthcare information systems manufacturers. While at HIMA, he was responsible for handling the Association's FDA-related legal, regulatory, and Congressional issues. Before joining HIMA in 1987, Mr. Terman served as Associate Chief Counsel for Enforcement, U.S. Food and Drug Administration, where he received the prestigious Award of Merit for outstanding consumer protection efforts, and the Commendable Service Award in recognition of superior performance in litigating complex enforcement cases raising significant questions concerning the agency's jurisdiction and the scope of its authority. Mr. Terman worked for the U.S. Food and Drug Administration from 1976-1987. Mr. Terman has given hundreds of speeches and is a frequent lecturer before trade and professional groups including AdvaMed, RAPS, FDLI, IBC, AAMI, HMS and AFDO. In 1995, Mr. Terman successfully defended a former USCI Bard employee charged with conspiracy to defraud the FDA in U.S. George Maloney, et. al., in Boston Massachusetts. In 2007, Mr. Terman was honored by the Washingtonian Magazine as one of Washington, D.C.'s top FDA lawyers. Areas of Practice: Medical Device Law Bar Admissions: Court of Appeals of Maryland, 1976
University of Maryland School of Law, Baltimore, Maryland, 1976 Published Works: Food and Drug Administration Regulation of Blood Bank Software: The New Regulatory Landscape for Blood Establishments and Their Vendors, 38 Transfusion 86, 1998 Bard Case Set Bad Precedents, 14 Food Drug Cosm. & Medical Devices Law Digest No. 1:1-8, NY State Bar Association, 1997 The Medical Device Amendments of 1976 and 1990 A Statutory Overview, Sterilization Technology, Van Nostrand Reinhold New York, 1993 Chapters on Biomedical Instrumentation and Technology on the Safe Medical Devices Act of 1989 and Complying With the Medical Device Reporting Regulation, The Medical Device Industry, Science, Technology and Regulation in a Competitive Environment, 1990. |
||||||||